News summary

Same diagnosis, different disease? GSK wants to know

Source: Longevity Technology • Published: 09 Nov 2026, 17:59

Summarized by Masters of Longevity from Longevity Technology.

They will map circulating proteins to clinical outcomes in diverse patients.

Same diagnosis, different disease? GSK wants to know
Key Takeaways
  • Proteomic profiling is reported to reveal biological subtypes within diagnoses.
  • Linked protein signatures were found to potentially predict disease severity.
  • Stratifying patients by proteome was reported to inform trial design.
Read the full article at Longevity Technology ↗

Continue exploring

Recommended MoL Picks

MoL PickCan You Really Measure Whether You’re Aging More Slowly?A younger epigenetic-age score can look like proof that an intervention is working. A major new analysis shows which clocks detect change—and why movement is not yet the same as longer healthspan.MoL PickPlan Your Health Tests in Three MinutesThe free Personal Health Diagnostics Planner turns a short questionnaire into a ranked, personalised PDF: a clearer starting point for deciding which health checks deserve attention now.MoL PickBiotin for Hair Growth: The Weak Evidence—and the Blood-Test Risk Most People MissBiotin deficiency can affect hair. That does not mean more biotin makes healthy hair grow—and high doses can distort important laboratory results.